approval

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

FDA Defends Generic Drug Labeling Plan

By: Nancy Simon, PharmD c/o 2016 - Last November, the Food and Drug Administration (FDA) submitted a proposal for a…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

An Interview with an FDA Preceptor: Pharmacist’s Role at the FDA

By: Melissa Roy Co-Copy Editor [Graphics focused] - Our dedicated preceptor Kimberly Defronzo, RPh, MS, MBA is currently a Consumer…

12 years ago

Migraine Relief at the Push of a Button

By: Davidta Brown, Senior Staff Editor - A new therapeutic device has seemingly leapt from the pages of a science…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

Rho Chi Society’s 90th Annual Meeting: Keynote Address

By: Fawad Piracha, PharmD Candidate c/o 2016 - Rho Chi Society held its 90th annual meeting on Sunday, March 30,…

12 years ago

New Strides in Lupus Treatment

By: Daniel Mathan, PharmD Candidate c/o 2016, Anita Kachappilly, PharmD Candidate c/o 2016, & Amrita Singh, PharmD Candidate c/o 2015 -…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

New Legislation Redefines Oversight for Compounding Pharmacies

By: Davidta Brown, Senior Staff Editor - As the world of healthcare and its provision evolves, laws which organize and…

12 years ago

Prior Experience and the Growth of the Biosimilars Market

By: Davidta Brown, Senior Staff Editor - In 21st century medicine, pharmaceuticals have come to include compounds derived through novel…

12 years ago

Dietary Supplements and Their Potential Dangers

By: Fatema Elias, Staff Writer - With the New Year and everyone committing to their New Year resolutions, more and…

12 years ago

To Defend the People

By: Davidta Brown, Senior Staff Editor - As the world’s largest market for pharmaceuticals, the United States receives many medications…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Possible Inhaled Option for Diabetics

By: Sang Hyo Kim, Staff Editor - Near the end of December, the pharmaceutical company, MannKind Corp, will submit their…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

After 15 Years, First New Recombinant Coagulation Factor IX (Rixubis) Gains Orphan Drug Approval

By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

A Close Concurrence on Certolizumab (Cimzia®)

By: Sang Hyo Kim, Staff Editor - This year, on July 23rd, FDA advisers voted 7 to 6, with one…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Compounding at a Crossroads: New Boundaries in the Aftermath of Tragedy?

Davidta Brown, PharmD Candidate c/o 2017 -      The debate on the nature of compounding practice and the extent to…

13 years ago

FDA Takes Major Strides Towards Opioid Abuse Prevention

By: Ada Seldin PharmD Candidate c/o 2015 - On April 16th, 2013, the FDA approved the labeling change for the…

13 years ago

Helping Solve the Cruel Mystery

By: Erica Dimitropoulos, Senior Staff Editor - Lupus is highly unpredictable and occurs without warning; there is no known cause…

13 years ago

Pay to Delay: The Honest Truth

By: David Ong, Pharm.D. Candidate c/o 2014 - Our current healthcare system receives much criticism from the press as well…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

Regulation of Low to Moderate Risk Medical Devices by the Food and Drug Administration

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On March 22, 2013, Public Broadcasting Service (PBS) aired an episode of “Need…

13 years ago

Plan B® Pill Now Available Without Prescription to Women 15 Years of Age and Older

By: Bansri Patel - As of May 1st 2013, Plan B®, the brand name emergency contraception pill will now be…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

U.S. v Caronia: Misdemeanor or Constitutional Right?

By: Tamara Yunusova, Staff Editor - On December 3, 2012, the U.S. Second Circuit Court of Appeals became the first…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

College Of Pharmacy And Health Sciences – Name Change Ceremony Announcement

 The College of Pharmacy and Allied Health Professions has officially changed its name to the College of Pharmacy and Health…

14 years ago

Brand Vs. Generic: What Every Prescriber Should Know

By: Marina Yermolayeva, PharmD Candidate c/o 2013 - “I’m allergic to the generic; I need the brand name medication,” is…

14 years ago

DIA 2012: St. John’s Students Collaborate to Innovate in Philadelphia

By: Michael Cronin, Pharm.D.  Candidate c/o 2014 - The Drug Information Association (DIA) student chapter at St. John's University College…

14 years ago

Risk versus Benefit: Prescription to Over the Counter Medications

By: Maria A. Sorbera, Pharm.D. Candidate c/o 2013 -   Maria Sorbera was the 2011-2012 President of the Rho Chi…

14 years ago

Update: FTC Approves Medco and Express Scripts Merger

By: Mahdieh Danesh Yazdi, with Special Thanks to: Dr. Tomasz Jodlowski - In previous issues, we discussed an upcoming $29.1 billion…

14 years ago

Sativex®: A Realistic Option for Advanced Cancer Pain?

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 - Nabiximols (Sativex®) is a buccal spray that has been approved for use…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

Pharmacists in Alberta Allowed to Renew Prescriptions

By: Mohamed Dungersi - Starting July 1, 2012, Albertans will be able to have their prescriptions renewed at their local…

14 years ago

Express Scripts and Medco Merger

By: Mahdieh Danesh Yazdi - Express Scripts Inc., one of the nation’s top pharmacy benefit managers (PBMs), has announced a…

14 years ago

New Oral Direct Thrombin Inhibitors and Factor Xa Anticoagulants

By: Neal Shah - Anticlotting agents are staples in the prevention and treatment of thrombotic disorders, such as deep vein…

14 years ago

New York Lawmakers Tackle Prescription Drug Abuse

By: Mahdieh Danesh Yazdi - We have all heard the mortifying tales of recent attacks on pharmacies by addicts looking…

14 years ago

Xigris: A Worldwide Withdrawal

By: Khilna Patel, Pharm.D. Candidate c/o 2012 - On October 25 of this year, Eli Lilly and Company announced a…

14 years ago

Faculty Spotlight: Dr. Charles R. Ashby

By: Neal Shah - Dr. Ashby is a well-known Pharmacology professor for student pharmacists studying in their professional years. He…

15 years ago